BIOMAT Database Logo BIOMAT Database Logo

[Experience with fibrinolytic therapy in acute myocardial infarct (Czechoslovak Socialist Republic)]. 1979

K Sochor

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

K Sochor
[The early diagnosis of myocardial infarct (the Czechoslovak Socialist Republic)].
October 1988, Voenno-meditsinskii zhurnal,
K Sochor
[Fibrinolytic therapy in acute myocardial infarct].
December 1973, Schweizerische medizinische Wochenschrift,
K Sochor
[Fibrinolytic therapy in acute myocardial infarct].
January 2003, Casopis lekaru ceskych,
K Sochor
[Experiences with fibrinolytic therapy in acute myocardial infarct].
January 1972, Medicinski arhiv,
K Sochor
[Taeniarhynchiasis in the Czechoslovak Socialist Republic].
January 1982, Meditsinskaia parazitologiia i parazitarnye bolezni,
K Sochor
[Radiodiagnosis in the Czechoslovak Socialist Republic].
January 1985, Radiologia diagnostica,
K Sochor
[Initial experiences with fibrinolytic therapy of acute myocardial infarct].
February 1963, Deutsches medizinisches Journal,
K Sochor
Surveillance of acute respiratory diseases in the Czechoslovak Socialist Republic (CSSR).
January 1981, Czechoslovak medicine,
K Sochor
[Fibrinolytic therapy in myocardial infarct].
March 1967, Prensa medica argentina,
K Sochor
Statistical survey of the Czechoslovak Socialist Republic.
January 1980, Demosta,
Copied contents to your clipboard!